knowledge -WSS

knowledge

author：entertainment 2025-09-02 09:55:48 - browse：294

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： 3 medical device trends to watch in 2024

WSS

3 medical device trends to watch in 2024

3 medical device trends to watch in 2024

White House finalizes ITC's import ban of latest Apple Watches

U.K. sequencing study surfaces new findings about tumor DNA

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

J&J to buy cancer drug developer Ambrx Biopharma

explore

knowledge

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How a scoliosis diagnosis changed the life of one young dancer

Dobbs anniversary: the lost opportunity of abortion as health care

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Health AI adoption puts security, privacy startups on investors' radar

Duchenne breakthrough therapy leaves behind pioneering families

The FDA must approve intranasal treatments for anaphylaxis

Dobbs anniversary: the lost opportunity of abortion as health care

Plastic surgeons increase patient psychiatric screenings

explore

Methadone treatment changes are coming. Do they go far enough?

Colonoscopy prep: Liquid

Morgan Health, with ambitious aims, wants you to know it’s still here

Plastic surgeons increase patient psychiatric screenings

How a scoliosis diagnosis changed the life of one young dancer

White House finalizes ITC's import ban of latest Apple Watches

focus

leisure time

explore

focus